MERS

Over the next 20 to 30 years, the world will suffer a pandemic with the potential “to bring humanity to its knees,” epidemiologist Larry Brilliant, M.D., told CNN in April. He was talking about new strains of influenza found in birds across the world. Yes, it’s the flu — not...

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) said Thursday it’s observed a 100-percent antibody response in a phase I study for a Zika virus vaccine and a 92 percent antibody response in a phase I study for a MERS vaccine. The findings were presented at a Coalition for Epidemic Preparedness...

Inovio Pharmaceuticals Inc (NASDAQ: INO) plans to complete its testing of a Zika vaccine in mice and monkeys by the third quarter of this year before moving to a Phase 1 study in Q4, a company spokesperson told Benzinga. The company said it plans to produce between 5,000 and 10,000 doses by Q3...